Andreas Kronbichler
Andreas Kronbichler is Professor and Head of Department of Internal Medicine IV, Nephrology and Hypertension, at Medical University Innsbruck, Austria, where he also completed his medical training. Professor Kronbichler was a Principal Site Investigator for the ADVOCATE and GOOD-IDeS01 and 02 trials. He is the Lead of an Investigator-Initiated Trial (IIT) called OBELIX-NEPHROSIS. He has over 350 peer-reviewed publications and is a reviewer of major journals in medicine, nephrology and rheumatology. His research focuses on ANCA-associated vasculitis, anti-GBM disease and nephrotic syndrome. Professor Kronbichler is the Past-Chair of the European Renal Association (ERA) Immunonephrology Working Group (ERA) and a Distinguished Fellow of the European Renal Association (ERA). In 2023, he was awarded the Nils-Alwall-Preis by the German Society of Nephrology (DGfN) and was awarded the Eberhard Ritz Award of the ERA in 2024.
